NUCLEAR BONE IMAGING IN METASTATIC CANCER OF THE PROSTATE

被引：0
|
作者：
POLLEN, JJ
GERBER, K
ASHBURN, WL
SCHMIDT, JD
机构：
[1] UNIV CALIF SAN DIEGO, MED CTR, DEPT RADIOL, DIV NUCL MED, SAN DIEGO, CA 92103 USA
[2] UNIV CALIF SAN DIEGO, MED CTR, DIV UROL, SAN DIEGO, CA 92103 USA
来源：
CANCER | 1981年 / 47卷 / 11期
关键词：
D O I：
10.1002/1097-0142(19810601)47:11<2585::AID-CNCR2820471113>3.0.CO;2-U
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A reproducible technique of bone scanning in prostatic cancer is described that helps ensure the production of successive studies of highly comparable technical quality. Through an analysis of survival data based on changes in distribution, anatomic extent and intensity of bone scan abnormalities in patients with advanced prostatic cancer, alterations in the appearance of the bone scan correlate closely with disease activity and have great prognostic significance.
引用
收藏
页码：2585 / 2594
页数：10
相关论文
共 50 条
  • [21] Prolonged survival with metastatic prostate cancer to bone
    Pisters, LL
    Troncoso, P
    Navone, N
    JOURNAL OF UROLOGY, 1998, 159 (06): : 2100 - 2100
  • [22] Novel Imaging in Detection of Metastatic Prostate Cancer
    Smith, Clayton P.
    Laucis, Anna
    Harmon, Stephanie
    Mena, Esther
    Lindenberg, Liza
    Choyke, Peter L.
    Turkbey, Baris
    CURRENT ONCOLOGY REPORTS, 2019, 21 (04)
  • [23] Molecular Imaging of Recurrent and Metastatic Prostate Cancer
    Ware, Robert E.
    Williams, Scott
    Hicks, Rodney J.
    SEMINARS IN NUCLEAR MEDICINE, 2019, 49 (04) : 280 - 293
  • [24] New developments in the imaging of metastatic prostate cancer
    Beauregard, Jean-Mathieu
    Pouliot, Frederic
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2014, 8 (03) : 265 - 270
  • [25] Novel Imaging in Detection of Metastatic Prostate Cancer
    Clayton P. Smith
    Anna Laucis
    Stephanie Harmon
    Esther Mena
    Liza Lindenberg
    Peter L. Choyke
    Baris Turkbey
    Current Oncology Reports, 2019, 21
  • [26] Integrated Multimodal Imaging of Dynamic Bone-Tumor Alterations Associated with Metastatic Prostate Cancer
    Brisset, Jean-Christophe
    Hoff, Benjamin A.
    Chenevert, Thomas L.
    Jacobson, Jon A.
    Boes, Jennifer L.
    Galban, Stefanie
    Rehemtulla, Alnawaz
    Johnson, Timothy D.
    Pienta, Kenneth J.
    Galban, Craig J.
    Meyer, Charles R.
    Schakel, Timothy
    Nicolay, Klaas
    Alva, Ajjai S.
    Hussain, Maha
    Ross, Brian D.
    PLOS ONE, 2015, 10 (04):
  • [27] Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancer
    Inaba, Koji
    Tsuchida, Keisuke
    Kashihara, Tairo
    Umezawa, Rei
    Takahashi, Kana
    Okuma, Kae
    Murakami, Naoya
    Ito, Yoshinori
    Igaki, Hiroshi
    Sumi, Minako
    Nakayama, Yuko
    Shinoda, Yasuo
    Hara, Tomohiko
    Matsui, Yoshiyuki
    Komiyama, Motokiyo
    Fujimoto, Hiroyuki
    Itami, Jun
    JOURNAL OF RADIATION RESEARCH, 2021, 62 (03) : 511 - 516
  • [28] Bone health practices in metastatic prostate cancer (mPCA)
    Eule, Corbin Jeffrey
    Hu, Junxiao
    Gilbert, Danielle
    Eskandar, Joy
    Lam, Elaine T.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Exploring metabolic vulnerabilities of metastatic prostate cancer to bone
    Mossa, Federica
    Robesti, Daniele
    Vellano, Christopher
    Titus, Mark
    Marszalek, Joe
    Frigo, Daniel
    Logothetis, Christopher
    Gujral, Taranjit
    Dondossola, Eleonora
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Serum follistatin in patients with prostate cancer metastatic to the bone
    Francesca Maria Tumminello
    Giuseppe Badalamenti
    Fabio Fulfaro
    Lorena Incorvaia
    Marilena Crescimanno
    Carla Flandina
    Maria Vittoria Sepporta
    Gaetano Leto
    Clinical & Experimental Metastasis, 2010, 27 : 549 - 555
12345